Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Growth hormone responses to growth hormone-releasing hormone and clonidine in patients with type I diabetes and in normal controls: effect of age, body mass index and sex.
Jacobs ML, Nathoe HM, Blankestijn PJ, Stijnen T, Weber RF. Jacobs ML, et al. Among authors: nathoe hm. Clin Endocrinol (Oxf). 1996 May;44(5):547-53. doi: 10.1046/j.1365-2265.1996.713534.x. Clin Endocrinol (Oxf). 1996. PMID: 8762731
Response to Letter to the Editor: Risk Factors of Pulmonary Embolism.
Grobben RB, Frima C, Nathoe HM, Van Herwaarden JA. Grobben RB, et al. Among authors: nathoe hm. Eur J Vasc Endovasc Surg. 2020 Jan;59(1):155-156. doi: 10.1016/j.ejvs.2019.09.001. Epub 2019 Oct 17. Eur J Vasc Endovasc Surg. 2020. PMID: 31629654 No abstract available.
Risk of elevated resting heart rate on the development of type 2 diabetes in patients with clinically manifest vascular diseases.
Bemelmans RH, Wassink AM, van der Graaf Y, Nathoe HM, Vernooij JW, Spiering W, Visseren FL; SMART Study Group. Bemelmans RH, et al. Among authors: nathoe hm. Eur J Endocrinol. 2012 Apr;166(4):717-25. doi: 10.1530/EJE-11-1017. Epub 2012 Jan 27. Eur J Endocrinol. 2012. PMID: 22285702
Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
van de Woestijne AP, van der Graaf Y, Westerink J, Nathoe HM, Visseren FL. van de Woestijne AP, et al. Among authors: nathoe hm. Am J Cardiol. 2015 Feb 15;115(4):441-6. doi: 10.1016/j.amjcard.2014.11.021. Epub 2014 Nov 29. Am J Cardiol. 2015. PMID: 25554536
The relation between HbA1c and cardiovascular events in patients with type 2 diabetes with and without vascular disease.
Kranenburg G, van der Graaf Y, van der Leeuw J, Nathoe HM, de Borst GJ, Kappelle LJ, Visseren FL, Westerink J; SMART Study Group. Kranenburg G, et al. Among authors: nathoe hm. Diabetes Care. 2015 Oct;38(10):1930-6. doi: 10.2337/dc15-0493. Epub 2015 Aug 25. Diabetes Care. 2015. PMID: 26307606
Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population.
Hendriks EJ, Westerink J, de Jong PA, de Borst GJ, Nathoe HM, Mali WP, van der Graaf Y, van der Schouw YT, Beulens JW; SMART Study Group. Hendriks EJ, et al. Among authors: nathoe hm. Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):412-7. doi: 10.1161/ATVBAHA.115.306657. Epub 2015 Dec 29. Arterioscler Thromb Vasc Biol. 2016. PMID: 26715681
HDL Cholesterol as a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes.
Sharif S, van der Graaf Y, Nathoe HM, de Valk HW, Visseren FL, Westerink J; SMART Study Group. Sharif S, et al. Among authors: nathoe hm. Diabetes Care. 2016 Aug;39(8):1424-30. doi: 10.2337/dc16-0155. Epub 2016 May 23. Diabetes Care. 2016. PMID: 27222511
Association of obesity, diabetes and hypertension with cognitive impairment in older age.
Feinkohl I, Lachmann G, Brockhaus WR, Borchers F, Piper SK, Ottens TH, Nathoe HM, Sauer AM, Dieleman JM, Radtke FM, van Dijk D, Pischon T, Spies C. Feinkohl I, et al. Among authors: nathoe hm. Clin Epidemiol. 2018 Jul 25;10:853-862. doi: 10.2147/CLEP.S164793. eCollection 2018. Clin Epidemiol. 2018. PMID: 30100759 Free PMC article.
Thyroid-stimulating hormone levels in the normal range and incident type 2 diabetes mellitus.
de Vries TI, Kappelle LJ, van der Graaf Y, de Valk HW, de Borst GJ, Nathoe HM, Visseren FLJ, Westerink J; SMART study group. de Vries TI, et al. Among authors: nathoe hm. Acta Diabetol. 2019 Apr;56(4):431-440. doi: 10.1007/s00592-018-1231-y. Epub 2018 Sep 27. Acta Diabetol. 2019. PMID: 30259116 Free PMC article.
The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.
van der Leeuw J, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle LJ, Visseren FL; SMART study group. van der Leeuw J, et al. Among authors: nathoe hm. Heart. 2014 Sep 15;100(18):1421-9. doi: 10.1136/heartjnl-2014-305490. Epub 2014 May 9. Heart. 2014. PMID: 24817441
112 results
Jump to page
Feedback